Adcendo
Phase 1/2Adcendo ApS is a global clinical-stage biotech company dedicated to developing highly differentiated first and best-in-class antibody-drug conjugates (ADCs) for targeted treatment of cancer.
Founded
2017
Focus
AntibodiesBiologics
About
Adcendo ApS is a global clinical-stage biotech company dedicated to developing highly differentiated first and best-in-class antibody-drug conjugates (ADCs) for targeted treatment of cancer.
Funding History
2Total raised: $160M
Series B$109MNovo HoldingsOct 15, 2023
Series A$51MYska VentureJul 15, 2021
Company Info
TypePrivate
Founded2017
LocationCopenhagen, Denmark
StagePhase 1/2
Contact
SIMILAR COMPANIES
MipSalus
Pre-clinical · Copenhagen
FluoGuide
Pre-clinical · Copenhagen
Fuse Vectors
Pre-clinical · Copenhagen
Fida Biosystems
Pre-clinical · Copenhagen
CerCell
Pre-clinical · Copenhagen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile